VERONICA JONES: Open Payments
NPI 1891127262 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 68 payments from 15 companies in 2025. Trend: 2023 $1,237 · 2024 $1,210 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $217 |
| Actelion Pharmaceuticals US, Inc. | 7 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $202 |
| JAZZ PHARMACEUTICALS INC. | 6 | $195 |
| Viatris Specialty LLC | 6 | $111 |
| Electromed, Inc. | 11 | $96 |
| GENZYME CORPORATION | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Amgen Inc. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $43 |
Products named: XYWAV, TEZSPIRE, DUPIXENT, OPSUMIT, OFEV, YUPELRI, SMARTVEST, Ohtuvayre.
Industry payments across AL — which companies pay providers there.
